Skip to main content
. 2021 May-Jun;37(3):805–811. doi: 10.12669/pjms.37.3.3552

Table III.

Incidence of TdT-negative, CD34-negative and TdT/CD34 Double-negative ALL in present study and reported in other studies.

Antigens Present study results, n/N (%) Other studies
TdT- 41/843 (4.8) 11.4%25, 38%22
B-ALL CD34- 314/833 (37.6) 41%26, 44%22
CD34-/TdT- 23/826 (2.8) 5.7%25
TdT- 35/206 (16.9) 28.5%25, 57%22
T-ALL CD34- 149/200 (74.5) 78%22
CD34-/TdT- 22/198 (11) 0.5%27

n/N: No. of cases lacking the tested expression/ Total no. of cases tested